CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $93,804 | -36.2% | 4,052 | -27.8% | 0.05% | -32.5% |
| Q4 2022 | $146,982 | +14.8% | 5,610 | -13.6% | 0.08% | +51.0% |
| Q3 2022 | $128,000 | +13.3% | 6,490 | +0.8% | 0.05% | +21.4% |
| Q2 2022 | $113,000 | -34.3% | 6,441 | -38.9% | 0.04% | -45.5% |
| Q1 2022 | $172,000 | -5.5% | 10,536 | -5.6% | 0.08% | +11.6% |
| Q4 2021 | $182,000 | +13.0% | 11,158 | -11.7% | 0.07% | -2.8% |
| Q3 2021 | $161,000 | -14.4% | 12,632 | -5.0% | 0.07% | -7.8% |
| Q2 2021 | $188,000 | – | 13,299 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
| Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
| Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
| Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
| Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
| Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
| Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |